0.00
Fusion Pharmaceuticals Inc Borsa (FUSN) Ultime notizie
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Defense World
Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Fusion Pharmaceuticals (FUSN) Jumps: Stock Rises 9% - Yahoo Movies UK
Yahoo Movies UK
Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Fusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Shares Acquired by Avidity Partners Management LP - MarketBeat
MarketBeat
Superstring Capital Management LP Takes $440,000 Position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) - MarketBeat
MarketBeat
AstraZeneca closes $2M precision med company buy - Delaware Business Times
Delaware Business Times
AstraZeneca Complete Fusion Acquisition - European Pharmaceutical Manufacturer
European Pharmaceutical Manufacturer
AstraZeneca closes $2M precision med company buy - Delaware Business Times
Delaware Business Times
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Stock Holdings Lifted by NEOS Investment Management LLC - Defense World
Defense World
Astrazeneca completes $2.4bn acquisition of Fusion – Financial News - FinancialNews.co.uk
FinancialNews.co.uk
AstraZeneca completes acquisition of clinical-stage cancer drug company - delawarebusinessnow.com
delawarebusinessnow.com
AstraZeneca Completes $2.4B Deal To Buy Pharma Co. Fusion - Law360
Law360
AstraZeneca completes acquisition of biopharma company Fusion Pharmaceuticals - Free Malaysia Today
Free Malaysia Today
AstraZeneca completes Fusion Pharmaceuticals acquisition - Yahoo Finance
Yahoo Finance
AstraZeneca completes acquisition of biopharma company Fusion Pharma - Yahoo Finance
Yahoo Finance
Acquisition of Fusion completed - PharmiWeb.com
PharmiWeb.com
AstraZeneca completes Fusion Pharmaceuticals acquisition - Pharmaceutical Technology
Pharmaceutical Technology
Astrazeneca swallows up Canada-based Fusion Pharmaceuticals in £1.5bn move - Yahoo Finance UK
Yahoo Finance UK
AstraZeneca completes acquisition of Fusion Pharmaceuticals - DirectorsTalk Interviews
DirectorsTalk Interviews
AstraZeneca completes acquisition of Fusion Pharmaceuticals - DirectorsTalk Interviews
DirectorsTalk Interviews
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Average Recommendation of “Hold” by Analysts - Defense World
Defense World
AstraZeneca finalizes Fusion Pharmaceuticals buyout - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
AstraZeneca concludes acquisition of Fusion Pharma - Medical Dialogues
Medical Dialogues
AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com - Investing.com Australia
Investing.com Australia
AstraZeneca finalizes Fusion Pharmaceuticals buyout - Investing.com India
Investing.com India
AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com - Investing.com
Investing.com
AstraZeneca completes acquisition of Fusion Pharmaceuticals - Seeking Alpha
Seeking Alpha
AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com - Investing.com UK
Investing.com UK
Acquisition of Fusion Pharmaceuticals Completed – Company Announcement - FT.com - Financial Times
Financial Times
The FUSN Stock Puzzle: Unraveling Fusion Pharmaceuticals Inc’s Fluctuating Performance - The InvestChronicle
The InvestChronicle
Fusion Pharmaceuticals Inc (FUSN) stock: A year of ups and downs – US Post News - US Post News
US Post News
Get in on Fusion Pharmaceuticals Inc's (FUSN) buy-in window today! – Sete News - SETE News
SETE News
Acquisition of Fusion Pharmaceuticals Completed - PR Newswire
PR Newswire
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
MarketBeat
Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $21.60 - Defense World
Defense World
Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $21.60 - Defense World
Defense World
Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement - Longview News-Journal
Longview News-Journal
Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $21.60 - MarketBeat
MarketBeat
Ontario court approves AstraZeneca/Fusion acquisition plan (NASDAQ:AZN) - Seeking Alpha
Seeking Alpha
Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement - Marketscreener.com
Marketscreener.com
Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement - Marketscreener.com
Marketscreener.com
Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement – Company Announcement - FT.com - Financial Times
Financial Times
Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement – Company Announcement - FT.com - Financial Times
Financial Times
Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase - MarketBeat
MarketBeat
After Plunging 14.9% in 4 Weeks, Here's Why the Trend Might Reverse for Fusion Pharmaceuticals Inc. (FUSN) - Yahoo Movies UK
Yahoo Movies UK
Fusion Pharmaceuticals Shareholders Back Major AstraZenica Deal - TipRanks.com - TipRanks
TipRanks
Fusion Pharmaceuticals Shareholders Back Major AstraZenica Deal - TipRanks.com - TipRanks
TipRanks
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca - citybiz
citybiz
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):